Ngā hua rapu - Ernst, Scott

Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline mā Batra, Anupam, Ernst, Scott, Potvin, Kylea, Fernandes, Ricardo, Power, Nicholas, Vanhie, James, Winquist, Eric

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma mā Kartolo, Adi, Deluce, Jasna, Hopman, Wilma M., Liu, Linda, Baetz, Tara, Ernst, Scott, Lenehan, John G.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma mā Bathe, Oliver F, Dowden, Scot, Sutherland, Francis, Dixon, Elijah, Butts, Charles, Bigam, David, Walley, Barb, Ruether, Dean, Ernst, Scott

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Primary Mediastinal Germ Cell Tumors—The University of Western Ontario Experience mā Lavi, Arnon, Winquist, Eric, Nair, Shiva M., Chin, Joseph L., Izawa, Jonathan, Fernandes, Ricardo, Ernst, Scott, Power, Nicholas E.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma mā Kudchadkar, Ragini, Ernst, Scott, Chmielowski, Bartosz, Redman, Bruce G, Steinberg, Joyce, Keating, Anne, Jie, Fei, Chen, Caroline, Gonzalez, Rene, Weber, Jeffrey

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases mā Bathe, Oliver F, Ernst, Scott, Sutherland, Francis R, Dixon, Elijah, Butts, Charles, Bigam, David, Holland, David, Porter, Geoffrey A, Koppel, Jennifer, Dowden, Scot

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer mā McPherson, Victor A., Rodrigues, George, Bauman, Glenn, Winquist, Eric, Chin, Joseph, Izawa, Jonathan, Potvin, Kylea, Ernst, Scott, Venkatesan, Varagur, Sexton, Tracy, Ahmad, Belal, Power, Nicholas

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer mā McPherson, Victor A., Rodrigues, George, Bauman, Glenn, Winquist, Eric, Chin, Joseph, Izawa, Jonathan, Potvin, Kylea, Ernst, Scott, Venkatesan, Varagur, Sexton, Tracy, Ahmad, Belal, Power, Nicholas

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care mā Miller, Fiona A, Hayeems, Robin Z, Bytautas, Jessica P, Bedard, Philippe L, Ernst, Scott, Hirte, Hal, Hotte, Sebastien, Oza, Amit, Razak, Albiruni, Welch, Stephen, Winquist, Eric, Dancey, Janet, Siu, Lillian L

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma mā Lacouture, Mario E., Dréno, Brigitte, Ascierto, Paolo Antonio, Dummer, Reinhard, Basset-Seguin, Nicole, Fife, Kate, Ernst, Scott, Licitra, Lisa, Neves, Rogerio I., Peris, Ketty, Puig, Susana, Sokolof, Jonas, Sekulic, Aleksandar, Hauschild, Axel, Kunstfeld, Rainer

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer mā Clemons, Mark, Liu, Michelle, Stober, Carol, Pond, Gregory, Jemaan Alzahrani, Mashari, Ong, Michael, Ernst, Scott, Booth, Christopher, Mates, Mihaela, Abraham Joy, Anil, Aseyev, Olexiy, Blanchette, Phillip, Vandermeer, Lisa, Tu, Megan, Thavorn, Kednapa, Fergusson, Dean

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Data... mā Harshman, Lauren C., Kroeger, Nils, Rha, Sun Young, Donskov, Frede, Wood, Lori, Tantravahi, Srinivas K., Vaishampayan, Ulka, Rini, Brian I., Knox, Jennifer, North, Scott, Ernst, Scott, Yuasa, Takeshi, Srinivas, Sandy, Pal, Sumanta, Heng, Daniel Y., Choueiri, Toni K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer mā Clemons, Mark, Ong, Michael, Stober, Carol, Ernst, Scott, Booth, Christopher, Canil, Christina, Mates, Mihaela, Robinson, Andrew, Blanchette, Phillip, Joy, Anil Abraham, Hilton, John, Aseyev, Olexiy, Pond, Gregory, Jeong, Ahwon, Hutton, Brian, Mazzarello, Sasha, Vandermeer, Lisa, Kushnir, Igal, Fergusson, Dean

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO) mā Moretto, Patricia, Wood, Lori, Emmenegger, Urban, Blais, Normand, Mukherjee, Som Dave, Winquist, Eric, Belanger, Eric Charles, MacRae, Robert, Balogh, Alexander, Cagiannos, Ilias, Kassouf, Wassim, Black, Peter, Czaykowski, Piotr, Gingerich, Joel, North, Scott, Ernst, Scott, Richter, Suzanne, Sridhar, Srikala, Reaume, M. Neil, Soulieres, Denis, Eisen, Andrea, Canil, Christina M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218) mā Hodi, F. Stephen, Chapman, Paul B., Sznol, Mario, Lao, Christopher D., Gonzalez, Rene, Smylie, Michael, Daniels, Gregory A., Thompson, John A., Kudchadkar, Ragini, Sharfman, William, Atkins, Michael, Spigel, David R., Pavlick, Anna, Monzon, Jose, Kim, Kevin B., Ernst, Scott, Khushalani, Nikhil I., van Dijck, Wim, Lobo, Maurice, Hogg, David

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Does HPV type affect outcome in oropharyngeal cancer? mā Nichols, Anthony C, Dhaliwal, Sandeep S, Palma, David A, Basmaji, John, Chapeskie, Corina, Dowthwaite, Samuel, Franklin, Jason H, Fung, Kevin, Kwan, Keith, Wehrli, Brett, Howlett, Chris, Siddiqui, Iram, Salvadori, Marina I, Winquist, Eric, Ernst, Scott, Kuruvilla, Sara, Read, Nancy, Venkatesan, Varagur, Todorovic, Biljana, Hammond, J Alex, Koropatnick, James, Mymryk, Joe S, Yoo, John, Barrett, John W

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations mā Albiges, Laurence, Hakimi, A. Ari, Xie, Wanling, McKay, Rana R., Simantov, Ronit, Lin, Xun, Lee, Jae-Lyun, Rini, Brian I., Srinivas, Sandy, Bjarnason, Georg A., Ernst, Scott, Wood, Lori A., Vaishamayan, Ulka N., Rha, Sun-Young, Agarwal, Neeraj, Yuasa, Takeshi, Pal, Sumanta K., Bamias, Aristotelis, Zabor, Emily C., Skanderup, Anders J., Furberg, Helena, Fay, Andre P., de Velasco, Guillermo, Preston, Mark A., Wilson, Kathryn M., Cho, Eunyoung, McDermott, David F., Signoretti, Sabina, Heng, Daniel Y.C., Choueiri, Toni K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa